[en] Previous studies have shown that histamine H(3) blockers potentiate the psychomotor and rewarding effects of cocaine. The present study examined the influence of thioperamide, an inverse H(3) receptor agonist, on the development of psychomotor sensitization and stereotyped activity induced by acute or intermittent cocaine in C57BL/6J mice. In the first experiment, mice were injected i.p. with saline, 10 or 20mg/kg thioperamide and saline or 8mg/kg cocaine, 10min apart, before being tested for their locomotor activity (providing data on the acute effects of thioperamide on cocaine-induced activity). Subsequently, mice were treated in the same manner every other day over six additional sessions. Sensitization was assessed by the responsiveness to a cocaine challenge (8mg/kg, i.p.) given 2 and 14days following the intermittent treatment. In experiments 2 and 3, we tested the effects of thioperamide (10 or 20mg/kg, i.p.) on gnawing and sniffing induced or affected by relatively high doses of cocaine (24 or 32mg/kg, s.c.), the drugs being given 10min apart. In the first experiment, both doses of thioperamide amplified cocaine-induced psychomotor hyperactivity almost on all experimental sessions. However, the histamine inverse agonist did not affect the induction of a psychomotor sensitization. All cocaine-treated mice showed similar levels of sensitized activity 2 and 14days after the intermittent treatments, whether they received thioperamide or not. The second and the third experiments showed that thioperamide did not affect gnawing and sniffing induced by cocaine. Taken together, these results indicate that H(3) receptors clearly contribute to the neurobiological mechanisms of the locomotor component of cocaine-induced psychomotor activation, but less likely to those underlying the development of cocaine behavioral sensitization or the expression of cocaine-induced oro-facial stereotypies.
Centre/Unité de recherche :
Centre de Neurosciences Cognitives et Comportementales - ULiège
Brabant, Christian ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Quertemont, Etienne ; Université de Liège - ULiège > Département des sciences cognitives > Psychologie quantitative
Tirelli, Ezio ; Université de Liège - ULiège > Département des sciences cognitives > Neuroscience comportementale et psychopharmacologie expér.
Langue du document :
Anglais
Titre :
Effects of the H-3-receptor inverse agonist thioperamide on the psychornotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice
Date de publication/diffusion :
2006
Titre du périodique :
Pharmacology, Biochemistry and Behavior
ISSN :
0091-3057
Maison d'édition :
Pergamon-Elsevier Science, Oxford, Royaume-Uni
Volume/Tome :
83
Fascicule/Saison :
4
Pagination :
561-569
Peer reviewed :
Peer reviewed vérifié par ORBi
Organisme subsidiant :
FRFC - Fonds de la Recherche Fondamentale Collective
Antoniou K., Kafetzopoulos E., Papadopoulou-Daifoti Z., Hyphantis T., and Marselos M. d-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 23 (1998) 189-196
Attoub S., Moizo L., Sobhani I., Laigneau J.P., Lewin M.J., and Bado A. The H3 receptor is involved in cholecystokinin inhibition of food intake in rats. Life Sci 69 (2001) 469-478
Brabant C., Charlier Y., Quertemont E., and Tirelli E. The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav Brain Res 160 (2005) 161-168
Brown R.E., Stevens D.R., and Haas H.L. The physiology of brain histamine. Prog Neurobiol 63 (2001) 637-672
Clapham J., and Kilpatrick G.J. Histamine H3 receptor-mediated modulation of water consumption in the rat. Eur J Pharmacol 232 (1993) 99-103
Clapham J., and Kilpatrick G.J. Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259 (1994) 107-114
Delfs J.M., Schreiber L., and Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10 (1990) 303-310
Dunn J.M., Inderwies B.R., Licata S.C., and Pierce R.C. Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine. Psychopharmacology 179 (2005) 172-180
Farzin D., and Attarzadeh M. Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat. Eur J Pharmacol 404 (2000) 169-174
Fox G.B., Esbenshade T.A., Pan J.B., Radek R.J., Krueger K.M., Yao B., et al. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313 (2005) 176-190
Glantz S. A primer of biostatistics. 4th edition (1997), McGraw-Hill, New York
Haas H., and Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4 (2003) 121-130
Heimer L., Zahm D.S., and Alheid G.F. Basal ganglia. In: Paxinos G. (Ed). The rat nervous system (1995), Academic Press, San Diego 579-628
Hyytiä P., Bäckström P., Piepponen P., and Ahtee L. Histamine H3-receptor antagonist thioperamide potentiates behavioral effects of cocaine. Eur J Pharm Sci 19 (2003) S21-S24
Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, d-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113 (2002) 939-955
Itoh Y., Nishibori M., Oishi R., and Saeki K. Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci Lett 48 (1984) 305-309
Kankaanpaa A., Lillsunde P., Ruotsalainen M., Ahtee L., and Seppala T. 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum. Pharmacol Toxicol 78 (1996) 317-321
Kankaanpaa A., Meririnne E., and Seppala T. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology 159 (2002) 341-350
Kelly P.H., and Iversen S.D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40 (1976) 45-56
Kelly P.H., Seviour P.W., and Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94 (1975) 507-522
King G.R., Pinto G., Konen J., Castro G., Tran S., and Hilburn C. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine. Eur J Pharmacol 449 (2002) 253-259
Komater V.A., Browman K.E., Curzon P., Hancock A.A., Decker M.W., and Fox G.B. H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization. Psychopharmacology 167 (2003) 363-372
Kuczenski R., and Segal D.S. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262 (1992) 1085-1094
Leurs R., Tulp M.T., Menge W.M., Adolfs M.J., Zuiderveld O.P., and Timmerman H. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116 (1995) 2315-2321
Leurs R., Bakker R.A., Timmerman H., and de Esch I.J. The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev, Drug Discov 4 (2005) 107-120
Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., and Bartolini A. Role of histamine in rodent antinociception. Br J Pharmacol 111 (1994) 1269-1279
Masukawa Y., Suzuki T., and Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology 111 (1993) 139-143
Michel A., and Tirelli E. Conditioned hyperkinesia induced by cocaine in mice is dose-dependent but not correlated with the unconditioned response or the contextually-sensitized response. Behav Pharmacol 13 (2002) 59-71
Molina-Hernandez A., Nunez A., and Arias-Montano J.A. Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum. NeuroReport 11 (2000) 163-166
Molina-Hernandez A., Nunez A., Sierra J.J., and Arias-Montano J.A. Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 41 (2001) 928-934
Monti J.M., Jantos H., Boussard M., Altier H., Orellana C., and Olivera S. Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness. Eur J Pharmacol 205 (1991) 283-287
Mori T., Narita M., Onodera K., and Suzuki T. Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. Nihon Shinkei Seishin Yakurigaku Zasshi 22 (2002) 73-78
Morisset S., Pilon C., Tardivel-Lacombe J., Weinstein D., Rostene W., Betancur C., et al. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. J Pharmacol Exp Ther 300 (2002) 621-628
Munzar P., Nosal R., and Goldberg S.R. Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats. Eur J Pharmacol 363 (1998) 93-101
Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.C., et al. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114 (2002) 173-193
Pollard H., Moreau J., Arrang J.M., and Schwartz J.C. A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 52 (1993) 169-189
Schlicker E., Fink K., Detzner M., and Gothert M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect 93 (1993) 1-10
Szumlinski K.K., Frys K.A., and Kalivas P.W. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats. Psychopharmacology (Berl) 165 (2003) 329-336
Tanda G., Ebbs A., Newman A.H., and Katz J.L. Effects of 4′-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313 (2005) 613-620
Tirelli E., and Witkin J.M. Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57Bl/6J mice. J Pharmacol Exp Ther 273 (1995) 7-15
Tirelli E., Geter-Douglass B., and Witkin J.M. gamma-Aminobutyric acidA agonists differentially augment gnawing induced by indirect-acting dopamine agonists in C57BL/6J mice. J Pharmacol Exp Ther 284 (1998) 116-124
Tolliver B.K., and Carney J.M. Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol Biochem Behav 48 (1994) 733-739
Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 (2000) 99-120
Zar J.H. Biostatistical analysis. 4th edition (1999), Prentice Hall, New Jersey
